Aug 18, 2021 7:00am EDT Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
Aug 09, 2021 7:05am EDT Sutro Biopharma Reports Second Quarter 2021 Financial Results, Business Highlights and Anticipated Second Half 2021 Milestones
Jul 29, 2021 7:00am EDT Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference
Jun 01, 2021 7:00am EDT Sutro Biopharma Earns Milestone Payment from Bispecific Antibody-Drug Conjugate Collaboration with Merck KGaA, Darmstadt, Germany
May 19, 2021 5:00pm EDT Sutro Biopharma Announces Additional Data for Dose-Escalation Phase 1 Study of STRO-002 to be Presented at ASCO 2021
May 07, 2021 7:00am EDT Sutro Biopharma Reports First Quarter 2021 Financial Results, Business Highlights and 2021 Anticipated Milestones
Apr 20, 2021 7:00am EDT Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer
